Skip to main content

Articles By Jack Cush, MD

A Rheumatology State of Mind

In 2012, a Medscape survey of US physicians revealed rheumatology as the most satisfying of medical specialties. This came as a surprise to many as rheumatologists see themselves as the Rodney Dangerfields of medical specialists.

Read Article
100_3376.JPG

Economic Impact of Biosimilars

According to the Federal Trade Commission biosimilars have the potential to save the U.S. healthcare system $250 billion through 2022.

Read Article
liver.jpg

Hepatotoxicity and TNF Inhibitors

Hepatic enzyme elevations with TNF inhibitor use is not uncommon.

Read Article
Blau.syndrome.jpg

Blau Syndrome - the Prototypic Autoinflammatory Granulomatous Disorder

The defining triad of Blau's syndrome includes granulomatous polyarthritis, dermatitis and uveitis.  This rare, monogenic, autosomal dominant disorder stems from a "gain in function" mutation of the pattern recognition receptor NOD2.

Read Article
female-160521_1280.png

Rheum by the Numbers: Inflammatory Back Pain

Nearly 20% Americans have chronic back pain, but 5-6% have inflammatory back pain. These numbers were derived from the 2010 National Health and Nutrition Examination Survey that showed the USA prevalence of axial spondyloarthritis to be 1-1.4% and ankylosing spondylitis to be 0.5%.

Read Article
pills.jpg

RA Compliance Undermines Treatment Success

Researchers at MD Anderson Cancer Center in Houston prospectively studied 107 RA patients with regard to oral medication (DMARDs, steroids) adherence. They report that adherence was low, ranging from 58-71% overall.

Read Article
120px-ShinglesDay2_ed.JPG

Zoster Risk is Similar Among Different MOA Biologics

The risk of new H zoster infection was studied among nearly 30,000 new biologic starts and compared rates seen with abatacept, adalimumab, rituximab, infliximab, etanercept, tocilizumab, certolizumab or golimumab initiation.

Read Article
hudsonpsoriasis.jpg

Patient perspectives in the management of psoriasis and PsA

A psoriasis population survey finds psoriasis or psoriatic arthritis in 1.4%-3.3% of North American and European households.  Many (27-53%) rated their disease as “severe”.

Read Article
×